Global Digital Therapeutics market size 2024, Forecast To 2033

29 Jan, 2024

The digital therapeutics market has experienced exponential growth, increasing from $7.05 billion in 2023 to $8.93 billion in 2024, with a compound annual growth rate (CAGR) of 26.7%. The growth in the historic period is attributed to an aging population, the prevalence of chronic diseases, the adoption of digital health, considerations of healthcare costs and efficiency, remote patient monitoring, and the surge in pandemic-induced demand. Looking ahead to 2028, the market is projected to continue its exponential growth, reaching $23.49 billion with a CAGR of 27.4%. This anticipated expansion is linked to the increasing adoption of personalized medicine, health data interoperability, value-based care models, a growing focus on mental health and well-being, considerations of healthcare access and equity, the rise in cybersecurity and data protection, and the escalating demand for population health management. Major trends in the forecast period include the expansion of IoT devices and sensors, artificial intelligence in healthcare, wearable health technology, technological advancements, and product innovations.

Global Digital Therapeutics Market Key Driver

The digital therapeutics market is witnessing growth due to the widespread use of smartphones and tablets. The State of Mobile Internet Connectivity Report 2023 by GSMA revealed that 54% of the world's population owned smartphones in 2022. Smartphones and tablet-based healthcare apps contribute to the growth of the digital therapeutics market, providing accessible and efficient healthcare solutions.

Get A Free Sample Of The Global Digital Therapeutics Market Report

Global Digital Therapeutics Market Segments

The global digital therapeutics market covered in this report is segmented –
1) By Product: Software, Devices
2) By Sales Channel: Business-To-Business (B2B), Business-To-Consumers (B2C)
3) By Application: Preventive Applications, Treatment Or Care-Related Applications
By Geography: The regions covered in the Digital Therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe,North America, South America, Middle East, and Africa. North Americawas the largest region in the digital therapeutics market in 2023. The Asia-Pacificis expected to be the fastest-growing region in the forecast period. The regions covered in the digital therapeutics market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Major Digital Therapeutics Industry Players

Omada Health Inc., WellDoc Inc., 2Morrow Inc., Livongo Health, Propeller Health, Pear Therapeutics, Canary Health Inc., Noom Health Inc., Mango Health Inc., Akili Interactive Labs, Better Therapeutics, Happify Health, Kaia Health, Medtronic plc, Teladoc Health Inc., Fitbit Health Solutions, EMulate Therapeutics, BigHealth, DarioHealth, IQVIA, JOGO Health, SilverCloud Health, Biofourmis Inc., Prosoma, Virta Health Corp., One Drop Inc., Lark Health, Riva, Xealth, CogniFit Ltd.

Get The Full Global Digital Therapeutics Market Report

Digital Therapeutics Market Overview

Digital therapeutics (DTx) are the products that give evidence-based therapeutic treatments to patients through high-quality software applications in order to prevent, manage, or treat a medical ailment or disease.

Digital Therapeutics Global Market Report 2023 provides data on the global digital therapeutics market such as market size, growth forecasts, segments and geographies, competitive landscape including leading competitors’ revenues, profiles and market shares. The digital therapeutics market report identifies opportunities and strategies based on market trends and leading competitors’ approaches.